Breakthrough: Ibuprofen/nitazoxanide/azithromycin: a battle changer
personalized COVID-19 telemedicine five days protocol
Abstract
Until recently, ibuprofen has been avoided in all COVID-19 protocols
world-wide. The author has been trying since March, 2020 to publish a
paper that disputes this unfortunate incident and he finally managed
since May 2020 to publish two manuscripts that not only prove
non-steroidal anti-inflammatory drugs not harmful for COVID-19, rather
they were shown to possess a potential to cure the disease based on a
unique new theory suggested to explain COVID-19 pathogenesis and he
suggested NSAIDs to be added to unique protocol he suggested using
nitazoxanide/azithromycin to manage early cases of COVID-19. In this
manuscript, considered the fourth related to the subject, the author
represents the first clinical results of using
NSAIDs/Nitazoxanide/Azithromycin protocol, used partly or fully, that
includes relatively cheap FDA approved drugs used in seventeen Egyptian
patients, whether confirmed or suspected, including children, adults and
two pregnant ladies whom have been mostly symptoms-free in five days.
The manuscripts also presents a road-map to illustrate how to deal
efficiently with early cases of COVID-19 according to the author’s
clinical experience.